Research article · 3 May 2011
Research articlePublished 2014
Potency and Stability of Intradermal Capsaicin: Implications for Use as a Human Model of Pain in Multicenter Clinical Trials
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Intradermally injected capsaicin has been used extensively both as a human pain model and to assess analgesic efficacy. Factors such as dose, formulation, route, and site are known to affect its sensitivity. We determined whether potency and stability of capsaicin solutions were further sources of variability when following strict manufacturing guidelines. Capsaicin solution (1.0 mg/mL) was prepared according to Current Good Manufacturing Practice (cGMP) guidelines and aseptically filled into sterile amber borosilicate vials and stored at 5°C, 25°C, and 30°C. All samples were analyzed at one, three, six, and twelve months. Chemical stability was determined using HPLC and physical stability was evaluated by visual inspection of color changes, clarity, particulate matter, and product/ container closure abnormalities during each sampling time. Capsaicin intradermal injection was found to be sterile and retained 95% of the initial concentration for at least one year, regardless of studied storage temperatures (P
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 2020
A natural cation exchanger, clinoptilolite effects on bones in an osteoporosis animal model and randomized human clinical trial
Case report · 22 Jan 2016
Capsaicin 8% Patch Compared with Pregabalin in the Treatment of Nondiabetic Peripheral Neuropathic Pain: Elevate Trial
Short communication · 6 Sep 2018
Suitability of Stimuli evoked Hypersensitivities in Hind paws as a Clinically Relevant Pain Behavioural Measure in Rat Model of Walker 256 Breast Cancer Cell-induced Bone Pain: An Overview
Conference abstract · 15 Oct 2013
Inhibitors of fatty acid amide hydrolase (FAAH): SAR and results in pre-clinical pain models
More from this journal
The newest in Journal of Clinical & Experimental Pharmacology.
Article · 9 Nov 2026
Balancing Efficacy and Tolerability in Nasal Decongestion: A Rationale for the Oxymetazoline and Dexpanthenol Combination
Article · 23 Feb 2026
A Thorough Overview of Polycystic Ovary Syndrome (PCOS) in Female Rats
Article · 19 Dec 2025
Theoretical Pharmacology: Understanding Drug Action Through Models and Principles
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Pharmacology
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Pavan Balabathula”
- BylineArticles whose byline prints “Himanshu Bhattacharjee”
- BylineArticles whose byline prints “Laura A Thoma”
- BylineArticles whose byline prints “Robert J Nolly”
- BylineArticles whose byline prints “Frank P Horton”
- BylineArticles whose byline prints “Gwendolyn D Stornes”
- BylineArticles whose byline prints “Jim Y Wan”
- BylineArticles whose byline prints “Ian M Brooks”

